The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded an increase of 199.07%. However, over the last six months, the performance has been weaker by 20.90%. The price of ARQT decreased -0.21% over the last 30 days. And in the last five days, it has surged by 13.38%.
Arcutis Biotherapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $13.17 on 04/09/24, while the lowest value for the same period was recorded at $1.76 on 12/01/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ARQT Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Arcutis Biotherapeutics Inc’s current trading price is -26.65% away from its 52-week high, while its distance from the 52-week low is 448.86%. The stock’s price range during this time has been between $1.76 and $13.17. The trading volume for the Healthcare sector company’s shares reached about 3.29 million for the day, which was higher than the average daily volume of 2.0 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 8.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.13B and boasts a workforce of 296 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.59, with a change in price of +1.03. Similarly, Arcutis Biotherapeutics Inc recorded 2,251,530 in trading volume during the last 100 days, posting a change of +11.94%.
ARQT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 1.11. Similarly, the long-term debt-to-equity ratio is also 1.11.
ARQT Stock Stochastic Average
Today’s raw stochastic average for Arcutis Biotherapeutics Inc over the last 50 days is 49.39%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 87.17%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 63.23% and 44.38%, respectively.
